Stravencon is an EU-based company sourcing generic finished-product pharmaceuticals in China and distributing them to EU health care institutions and government health programs.  These consistently high-quality, regulatory-compliant generics are the most cost-effective available, meeting the demand for EU health care cost reduction.

Stravencon carefully selects long-term Chinese pharmaceutical partners, helps them manufacture products to EU regulatory standards, obtains regulatory approvals and markets the products in countries with diverse health systems and languages.


Stravencon also assists EU and US based companies identify Chinese partners for new and innovative pharmaceutical and biotechnology technologies